Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
78°
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
Photos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Best of 2023
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Atricure Inc
(NQ:
ATRC
)
25.44
+1.09 (+4.48%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Atricure Inc
< Previous
1
2
3
4
5
Next >
AtriCure Receives Expanded CE-Mark Indication for AtriClip® Devices for the Reduction of Stroke in Patients with Atrial Fibrillation
August 22, 2024
From
AtriCure, Inc.
Via
Business Wire
Navigating 6 Analyst Ratings For AtriCure
July 31, 2024
Via
Benzinga
ATRC Stock Earnings: AtriCure Meets EPS, Beats Revenue for Q2 2024
July 30, 2024
ATRC stock results show that AtriCure met analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.
Via
InvestorPlace
AtriCure Reports Second Quarter 2024 Financial Results
July 30, 2024
From
AtriCure, Inc.
Via
Business Wire
Analyst Ratings For AtriCure
July 08, 2024
Via
Benzinga
Cracking The Code: Understanding Analyst Reviews For AtriCure
May 02, 2024
Via
Benzinga
Key Takeaways From AtriCure Analyst Ratings
April 10, 2024
Via
Benzinga
AtriCure to Participate in the Canaccord Genuity 44th Annual Global Growth Conference
July 29, 2024
From
AtriCure, Inc.
Via
Business Wire
AtriCure Receives Regulatory Approval to Sell AtriClip® Devices in China
July 23, 2024
From
AtriCure, Inc.
Via
Business Wire
AtriCure to Announce Second Quarter 2024 Financial Results
July 09, 2024
From
AtriCure, Inc.
Via
Business Wire
Cracking The Code: Understanding Analyst Reviews For AtriCure
February 16, 2024
Via
Benzinga
Recap: AtriCure Q4 Earnings
February 15, 2024
Via
Benzinga
Have 20 Bucks? 7 Low-Priced Stocks That Could Double by 2025
June 28, 2024
Low priced stocks to buy for growth provide great value to investors in the $20 range and are expected to pop before 2025.
Via
InvestorPlace
12 Health Care Stocks Moving In Tuesday's Intraday Session
June 18, 2024
Via
Benzinga
AtriCure to Participate in the 2024 Leerink Partners Healthcare Crossroads Conference
May 15, 2024
From
AtriCure, Inc.
Via
Business Wire
ATRC Stock Earnings: AtriCure Misses EPS, Beats Revenue for Q1 2024
May 01, 2024
ATRC stock results show that AtriCure missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.
Via
InvestorPlace
Earnings Scheduled For February 15, 2024
February 15, 2024
Companies Reporting Before The Bell • Cognex (NASDAQ:CGNX) is estimated to report quarterly earnings at $0.10 per share on revenue of $188.59 million.
Via
Benzinga
AtriCure's Earnings: A Preview
February 14, 2024
Via
Benzinga
Key Takeaways From AtriCure Analyst Ratings
January 04, 2024
Via
Benzinga
AtriCure Reports First Quarter 2024 Financial Results
May 01, 2024
From
AtriCure, Inc
Via
Business Wire
AtriCure to Participate in the 2024 Bank of America Securities Healthcare Conference
April 30, 2024
From
AtriCure, Inc.
Via
Business Wire
AtriCure Announces Launch of the cryoSPHERE®+ Probe for Post-Operative Pain Management
April 18, 2024
From
AtriCure, Inc.
Via
Business Wire
AtriCure to Announce First Quarter 2024 Financial Results
April 10, 2024
From
AtriCure, Inc.
Via
Business Wire
AtriCure to Participate in the 23rd Annual Needham Virtual Healthcare Conference
March 26, 2024
From
AtriCure, Inc.
Via
Business Wire
Coinbase To Rally Around 45%? Here Are 10 Top Analyst Forecasts For Friday
February 16, 2024
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Via
Benzinga
AtriCure Reports Fourth Quarter 2023 and Full Year 2023 Financial Results
February 15, 2024
From
AtriCure, Inc.
Via
Business Wire
AtriCure to Announce Fourth Quarter and Full Year 2023 Financial Results and Participate in 2024 BTIG Medical Technology Conference
January 25, 2024
From
AtriCure, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
January 18, 2024
Via
Benzinga
AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2023, Provides Financial Outlook for 2024
January 08, 2024
From
AtriCure, Inc.
Via
Business Wire
AtriCure Appoints Shlomi Nachman to the Board of Directors
January 04, 2024
From
AtriCure, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.